Okyanos Heart Institute treats chronic ischemic heart disease for patients who have previously undergone interventions such as coronary bypass and/or stenting and no longer have options for additional interventions.
We carefully evaluate patient eligibility based on:
Stage of heart failure
Patient co-morbidities including diabetes and lung disease
Age of patient
Symptomatic vs. asymptomatic disease
Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy: The POSEIDON Randomized Trial
As a referring physician, we will work with you on a case-by-case basis to determine if cardiac cell therapy is an approach that may help your patient. Post treatment, Okyanos Heart Institute will provide copies of all diagnostic and treatment records.
To support the critical research function of Okyanos, we seek your ongoing partnership with our on-line patient registry. The objective of the registry is to capture key longitudinal data (e.g., echocardiography, stress test) post-treatment. Your participation in the registry will assist in the further progress of cardiac cell therapy and without doubt improve the quality of life for future patients suffering with heart failure. With your permission, Okyanos will send you all registry related publications.
The 5 Day Process for the Okyanos Stem Cell Treatment Video
Adult Stem Cell Therapy: Congestive Heart Failure Treatment Video